Iodine-124 Evuzumitide (AT-01)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iodine-124 Evuzumitide (AT-01), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis [Phase 2]